Raymond James & Associates Avid Bioservices, Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 10,100 shares of CDMO stock, worth $126,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,100
Previous 10,100
-0.0%
Holding current value
$126,149
Previous $72,000
58.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CDMO
# of Institutions
17Shares Held
6.75MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY5.11MShares$63.8 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL792KShares$9.9 Million0.0% of portfolio
-
Rothschild & CO Asset Management Us Inc. New York, NY200KShares$2.49 Million0.04% of portfolio
-
Cigogne Management Sa Luxembourg, N4189KShares$2.36 Million1.39% of portfolio
-
Millrace Asset Group, Inc.156KShares$1.95 Million1.8% of portfolio
About Avid Bioservices, Inc.
- Ticker CDMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,167,500
- Market Cap $776M
- Description
- Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...